[ad_1]
New York, Jan. 31, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Biobanking: Technologies and Global Markets” – https://www.reportlinker.com/p04417134/?utm_source=GNW
The biobanking market is segmented based on their application as basic/scientific research and clinical research/therapeutics. Each application segments’ historical and projected market revenues are provided in the report.
The global market for biobanking is also segmented based on sample type (as biofluids, tissue, stem cells, DNA/RNA and others) and ownership types (government agencies/public sector providers, academic institutes/universities, non-profit organizations and private organizations ). The market revenue for each geographical segment, including North America, Europe, Asia-Pacific and Rest of the World (ROW), have also been provided in the report.
For an in-depth understanding of the market, profiles of market participants are also part of this report. This report also discusses driving and restraining factors and key trends in the biobanking market.
This research covers biobanks dealing with basic science and clinical research.Forensic science, paternity testing, cryopreservation facilities or screening disease testing for newborns and fertility clinics dealing with ovum, sperm and embryo biobanks are not covered in this report.
Transplantation and graft-related biobanks dealing with heart valves, cornea and cartilage/tendon are also not covered. Tissue banks for orthopedic, spine, dental, maxillofacial surgery and stem cells biobank for regenerative medicine are also not covered in this report.
Report Includes:
– 22 data tables and 29 additional tables
– An up-to-date review and analysis of the global…
Full story available on Benzinga.com
[ad_2]
Source link
